Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Pflugers Arch ; 446(4): 437-46, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12733076

RESUMO

Continuous i.v. infusion of norepinephrine in rats has been shown to induce early interleukin (IL)-6 mRNA expression in the left ventricle (LV) which was followed by hypertrophy and fibrosis. In this study, two approaches were used. In the first, NE (0.1 mg/kg per hour) was infused i.v. in rats for several time periods, and freshly obtained ventricular myocardium was dissociated into myocyte (MC) and non-myocyte (NMC) fractions. Second, isolated adult MCs and fibroblasts were treated with NE (10 microM). NE infusion (4 h, in vivo) caused an 11-fold increase in IL-6 mRNA in both cell populations. In vitro treatment of isolated adult MCs for 2 h and of fibroblasts for 1 h with NE induced a 3.5- and 23-fold maximum increase, respectively, in IL-6 mRNA. After in vivo NE treatment, the expression of the mRNA of the transcriptional factor of IL-6, C/EBP-beta, was elevated earlier (after 45 min of NE infusion) than IL-6 mRNA (after 4 h) and was seen in MCs and NMCs. The mRNAs of both receptors of IL-6, the soluble IL6R and gp130, were increased subsequently to IL-6 mRNA. Gp130 was elevated after 24 h and, like IL6R, predominantly in NMCs. In contrast, the IL6R protein and the downstream regulator STAT3 were increased only in MCs after 24 h of NE infusion. The mRNA of C/EBP-delta, which is regulated by STAT3, was elevated only in myocytes.


Assuntos
Agonistas alfa-Adrenérgicos/farmacologia , Interleucina-6/genética , Miócitos Cardíacos/fisiologia , Norepinefrina/farmacologia , Transdução de Sinais/efeitos dos fármacos , Animais , Antígenos CD/genética , Proteínas Estimuladoras de Ligação a CCAAT/genética , Proteínas Estimuladoras de Ligação a CCAAT/metabolismo , Receptor gp130 de Citocina , Proteínas de Ligação a DNA/metabolismo , Feminino , Fibroblastos/fisiologia , Expressão Gênica/efeitos dos fármacos , Interleucina-6/metabolismo , Glicoproteínas de Membrana/genética , Fosforilação , RNA Mensageiro/análise , Ratos , Ratos Sprague-Dawley , Receptores de Interleucina-6/genética , Receptores de Interleucina-6/metabolismo , Fator de Transcrição STAT3 , Transativadores/metabolismo
2.
J Clin Invest ; 103(7): 945-52, 1999 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10194466

RESUMO

Immune mechanisms and the renin-angiotensin system are implicated in preeclampsia. We investigated 25 preeclamptic patients and compared them with 12 normotensive pregnant women and 10 pregnant patients with essential hypertension. Antibodies were detected by the chronotropic responses to AT1 receptor-mediated stimulation of cultured neonatal rat cardiomyocytes coupled with receptor-specific antagonists. Immunoglobulin from all preeclamptic patients stimulated the AT1 receptor, whereas immunoglobulin from controls had no effect. The increased autoimmune activity decreased after delivery. Affinity-column purification and anti-human IgG and IgM antibody exposure implicated an IgG antibody directed at the AT1 receptor. Peptides corresponding to sites on the AT1 receptor's second extracellular loop abolished the stimulatory effect. Western blotting with purified patient IgG and a commercially obtained AT1 receptor antibody produced bands of identical molecular weight. Furthermore, confocal microscopy of vascular smooth muscle cells showed colocalization of purified patient IgG and AT1 receptor antibody. The protein kinase C (PKC) inhibitor calphostin C prevented the stimulatory effect. Our results suggest that preeclamptic patients develop stimulatory autoantibodies against the second extracellular AT1 receptor loop. The effect appears to be PKC-mediated. These novel autoantibodies may participate in the angiotensin II-induced vascular lesions in these patients.


Assuntos
Autoanticorpos/imunologia , Pré-Eclâmpsia/imunologia , Receptores de Angiotensina/agonistas , Sequência de Aminoácidos , Angiotensina II/farmacologia , Antagonistas de Receptores de Angiotensina , Animais , Células Cultivadas , Feminino , Ventrículos do Coração/imunologia , Humanos , Imunoglobulina G/farmacologia , Imunoglobulina M/farmacologia , Dados de Sequência Molecular , Músculo Liso Vascular/imunologia , Contração Miocárdica/efeitos dos fármacos , Contração Miocárdica/imunologia , Naftalenos/farmacologia , Fragmentos de Peptídeos/farmacologia , Período Pós-Parto , Gravidez , Ratos , Ratos Wistar , Receptor Tipo 1 de Angiotensina , Receptor Tipo 2 de Angiotensina , Receptores de Angiotensina/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA